| Literature DB >> 28272319 |
Yueqiu Liu1, Nils T Nyberg2, Anna K Jäger3, Dan Staerk4.
Abstract
Radix Astragali is a component of several traditional medicines used for the treatment of type 2 diabetes in China. Radix Astragali is known to contain isoflavones, which inhibit α-glucosidase in the small intestines, and thus lowers the blood glucose levels. In this study, 21 samples obtained from different regions of China were extracted with ethyl acetate, then the IC50-values were determined, and the crude extracts were analyzed by 1H-NMR spectroscopy. A principal component analysis of the 1H-NMR spectra labeled with their IC50-values, that is, bioactivity-labeled 1H-NMR spectra, showed a clear correlation between spectral profiles and the α-glucosidase inhibitory activity. The loading plot and LC-HRMS/NMR of microfractions indicated that previously unknown long chain ferulates could be partly responsible for the observed antidiabetic activity of Radix Astragali. Subsequent preparative scale isolation revealed a compound not previously reported, linoleyl ferulate (1), showing α-glucosidase inhibitory activity (IC50 0.5 mM) at a level comparable to the previously studied isoflavones. A closely related analogue, hexadecyl ferulate (2), did not show significant inhibitory activity, and the double bonds in the alcohol part of 1 seem to be important structural features for the α-glucosidase inhibitory activity. This proof of concept study demonstrates that bioactivity-labeling of the 1H-NMR spectral data of crude extracts allows global and nonselective identification of individual constituents contributing to the crude extract's bioactivity.Entities:
Keywords: 1H-NMR spectroscopy; Radix Astragali; metabolomics; multivariate data analysis; type 2 diabetes; α-glucosidase inhibition assay
Mesh:
Substances:
Year: 2017 PMID: 28272319 PMCID: PMC6155417 DOI: 10.3390/molecules22030411
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Radix Astragali samples investigated and the IC50-values determined in the α-glucosidase inhibition assay of ethyl acetate extracts. The three most active extracts are typeset in bold.
| No. | Origin a | Voucher b | IC50 (µg/mL) c |
|---|---|---|---|
| 1 | Xihe, Gansu (cultivated) | HQ106 | 19 ± 0 |
| 2 | Kangding, Sichuan | HQ101 | 157 ± 13 |
| 4 | Songpan, Sichuan (cultivated) | HQ102 | 19 ± 1 |
| 5 | Longxi, Gansu (cultivated, 3 years) | HQ111 | >10,000 d |
| 6 | Litang, Sichuan (wild, >3 years) | HQ103 | 136 ± 7 |
| 7 | Litang, Sichuan (wild, 1–2 years) | HQ104 | 35 ± 1 |
| 10 | Zhangxian, Gansu (cultivated) | HQ119 | 71 ± 2 |
| 11 | Xiaojin, Sichuan (wild) | HQ105 | 107 ± 12 |
| 12 | Dangchang, Gansu (cultivated) | HQ110 | 27 ± 7 |
| 13 | Longxi, Gansu (cultivated) | HQ112 | 51 ± 2 |
| 14 | Lixian, Gansu (cultivated, 3 years) | HQ113 | 34 ± 1 |
| 15 | Minxian, Gansu (cultivated, 3 years) | HQ114 | 29 ± 1 |
| 16 | Jingyuan, Gansu (cultivated, 2 years) | HQ115 | 129 ± 38 |
| 17 | Jingyuan, Gansu (cultivated, 3–4 years) | HQ116 | >10,000 d |
| 18 | Zhangxian, Gansu (cultivated, 3 years) | HQ117 | 1457 ± 170 |
| 19 | Zhangxian, Gansu (cultivated, 2 years) | HQ118 | >5000 e |
| 20 | Wutaishan, Shanxi (cultivated) | HQ120 | 26 ± 1 |
| 21 | Neimenggu (cultivated) | HQ121 | >10,000 d |
a Province and county, cultivated or harvested in the wild, age of plant (if known); b Northwest Genuine Medicinal Materials Planting Cooperative (Jingyuan, Gansu, China); c IC50-values with 95% confidence intervals of the fitted parameter; d No inhibition at highest concentration (10 mg/mL); e 30% inhibition at 5 mg/mL.
Figure 1An expansion of 600 MHz 1H-NMR spectra of ethyl acetate extracts of Radix Astragali samples dissolved in DMSO-d6. The color and order of the spectra reflects the activity in the α-glucosidase inhibition assay according to the bar to the left. The number to the right is the number of the samples according to Table 1. Active extracts are those with IC50 values < 100 μg/mL and extracts with low activity are those with IC50 values ≥ 100 μg/mL. The non-active extract #19 showed only 30% inhibition at 5 mg/mL, and the remaining non-active extracts were arbitrarily set to 10 mg/mL for plotting purposes. The full spectral range 0–9 ppm can be seen in Supplementary Materials, Figure S3.
Figure 2(A) Principal component analysis (PCA) scores plot of component #3 vs. #1. Each marker represents one spectrum and solid lines between markers connect spectra of the same extract. The color of the markers represents the activity of the extracts in the α-glucosidase inhibition assay as described in the legend of Figure 1 and the color bar to the right. The numbers in parentheses are the percentage of the original variance that was captured in the specific component; (B) PCA scores plot of component #3 vs. #2 vs. #1. Each marker represents one spectrum. The color represents the activity of the extracts in the α-glucosidase assay as described in the legend of Figure 1 (red = active samples, blue = non-active samples).
Figure 3Two selected ranges of PCA-loading values of component #3 (top row) compared to 1H-NMR spectra of the most active extract (sample 3). The vertical scaling of the loadings are the same in both ranges, whereas the vertical scaling in the 1H-NMR spectrum is indicated by the horizontal grid line.
Figure 4HPLC-chromatograms from a time-sliced fractionation of 20 repetitive analytical-scale separations (each corresponding to 0.5 mg dry weight on-column) of Radix Astragali sample #3 extract (top); Chromatographic profiles at 280 nm are overlaid with the first separation in blue color and the last in red color (intermediate separations in green and yellow). The fraction numbers of the 40 fractions are indicated under the chromatographic profiles and the gradient elution program on the right ordinate. The sums of UV-intensities are shown as bars plotted along the retention time axis (bottom).
Figure 51H-NMR spectra of the 40 captured fractions dissolved in DMSO-d6 and plotted on the retention time axis according to their collection. The corresponding UV-chromatograms (first separation in blue color, last in red, intermediate in green and yellow, 20 in total) are plotted along the left-hand side and the summed NMR intensities are plotted as green bars on the right-hand side. The NMR-data were normalized so that the residual DMSO-signal (at 2.50 ppm) is of equal area for all spectra.
Figure 6Expansion of 1H-NMR spectra of the 40 fractions dissolved in DMSO-d6 and plotted on the retention time axis according to their collection. The corresponding UV-chromatograms (first in blue color, last in red, intermediate in green and yellow, 20 in total) are plotted along the left-hand side.
Figure 7(A) Structure of linoleyl ferulate (1) and hexadecyl ferrulate (2) and selected HMBC and ROESY correlations; (B) Experimental (top) and simulated spectra (600 MHz) of the olefinic methine protons of the spin system -CH2-C=C-CH2-C=C-CH2 where the coupling is 7 Hz to the external methylenes (3JH-8,H-9 and 3JH-13,H-14) and 6.6 Hz to the central methylene (3JH-10,H-11 and 3JH-11,H-12), whereas the olefinic methine protons are coupled with 10 Hz (cis, cis), 10 and 16 Hz (cis, trans) and 16 Hz (trans, trans). The chemical shift values of the methine protons were set to 5.333, 5.297, 5.295 and 5.335 ppm.
NMR spectroscopic data (DMSO-d6, 600 and 150 MHz for 1H and 13C, respectively) of compounds 1 and 2 acquired at 300 K.
| Pos. | 1 | 2 | ||
|---|---|---|---|---|
| δC a | δH ( | δC a | δH ( | |
| 1 | 166.7 | 166.9 | ||
| 2 | 114.4 | 6.43 d (15.9) | 114.3 | 6.44 d (16.0) |
| 3 | 144.8 | 7.52 d (15.9) | 144.8 | 7.52 d (16.0) |
| 4 | 124.3 | 123.1 | ||
| 5 | 111.1 | 7.28 d (1.7) | 110.8 | 7.29 d (1.7) |
| 6 | 148.2 | 148.3 | ||
| 7 | 149.2 | 149.1 | ||
| 8 | 115.4 | 6.78 d (8.1) | 115.3 | 6.78 d (8.1) |
| 9 | 123.0 | 7.09 dd (8.1, 1.7) | 123.1 | 7.09 dd (8.1, 1.7) |
| 1′ | 63.7 | 4.09 t (6.7) | 63.6 | 4.10 t (6.6) |
| 2′ | 28.1 | 1.61 m | 27.7 | 1.61 tt (7.3, 6.3) |
| 3′ | 25.3 | 1.32 m | 25.2 | 1.33 m |
| 4′ | 28.6 | 1.26 overlap | 28.6 | 1.22 overlap |
| 5′ | 28.6 | 1.26 overlap | 28.6 | 1.22 overlap |
| 6′ | 28.6 | 1.26 overlap | 28.6 | 1.22 overlap |
| 7′ | 28.8 | 1.26 overlap | 28.6 | 1.22 overlap |
| 8′ | 26.5 | 1.99 overlap | 28.6 | 1.22 overlap |
| 9′ | 129.6 | 5.31 m | 28.6 | 1.22 overlap |
| 10′ | 127.7 | 5.28 m | 28.6 | 1.22 overlap |
| 11′ | 25.1 | 2.71 t (6.6) | 28.6 | 1.22 overlap |
| 12′ | 127.7 | 5.28 m | 28.6 | 1.22 overlap |
| 13′ | 129.6 | 5.31 m | 28.6 | 1.22 overlap |
| 14′ | 26.5 | 1.99 overlap | 30.9 | 1.22 overlap |
| 15′ | 28.8 | 1.26 overlap | 22.0 | 1.24 overlap |
| 16′ | 28.8 | 1.26 overlap | 13.8 | 0.84 t (6.8) |
| 17′ | 21.9 | 1.24 overlap | - | - |
| 18′ | 13.9 | 0.85 t (6.8) | - | - |
| 6-OCH3 | 55.7 | 3.80 s | 55.5 | 3.80 s |
a Spectra referenced to residual DMSO signal at 2.50/39.51 ppm; b s = singlet, d = doublet, dd = double doublet, t = triplet, m = unresolved multiplet, overlap (for signals in the methylene envelope).